Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04858594 · ClinicalTrials.gov registry record
Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04858594 is a clinical trial that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 3 participants.
The verdict
NCT04858594 was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.
Interventions
- OTHER Planned Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04858594
The ClinicalTrials.gov registry entry for NCT04858594 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Planned Chemotherapy is the first listed.
NCT04858594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04858594 about?
NCT04858594 is a clinical study titled "Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy". This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.
What is the current status of trial NCT04858594?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-05-04. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04858594?
The interventions under investigation include: Planned Chemotherapy (OTHER).
Who is sponsoring clinical trial NCT04858594?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.